13-23730445-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_005932.4(MIPEP):c.2045G>A(p.Gly682Asp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00076 in 1,607,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005932.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIPEP | NM_005932.4 | c.2045G>A | p.Gly682Asp | missense_variant, splice_region_variant | 19/19 | ENST00000382172.4 | NP_005923.3 | |
MIPEP | XM_011535097.3 | c.1859G>A | p.Gly620Asp | missense_variant, splice_region_variant | 19/19 | XP_011533399.1 | ||
LOC105370113 | XR_007063722.1 | n.651+1168C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIPEP | ENST00000382172.4 | c.2045G>A | p.Gly682Asp | missense_variant, splice_region_variant | 19/19 | 1 | NM_005932.4 | ENSP00000371607.3 | ||
MIPEP | ENST00000433710.2 | n.238G>A | splice_region_variant, non_coding_transcript_exon_variant | 4/4 | 3 | |||||
MIPEP | ENST00000464194.3 | n.287G>A | splice_region_variant, non_coding_transcript_exon_variant | 2/2 | 2 | |||||
ENSG00000289332 | ENST00000691844.2 | n.385-4102C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00103 AC: 157AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000697 AC: 171AN: 245244Hom.: 0 AF XY: 0.000671 AC XY: 89AN XY: 132668
GnomAD4 exome AF: 0.000732 AC: 1065AN: 1455238Hom.: 0 Cov.: 28 AF XY: 0.000761 AC XY: 551AN XY: 724024
GnomAD4 genome AF: 0.00103 AC: 157AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.000861 AC XY: 64AN XY: 74358
ClinVar
Submissions by phenotype
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 04, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 02, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 682 of the MIPEP protein (p.Gly682Asp). This variant is present in population databases (rs150308123, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MIPEP-related conditions. ClinVar contains an entry for this variant (Variation ID: 392943). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 02, 2024 | Variant summary: MIPEP c.2045G>A (p.Gly682Asp) results in a non-conservative amino acid change located in the Peptidase M3A/M3B catalytic domain (IPR001567) of the encoded protein sequence, in the first nucleotide of exon 19 adjacent to the intron 18 / exon 19 3' splice acceptor site. Three of five in-silico tools predict a benign effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a cryptic 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0007 in 245244 control chromosomes. To our knowledge, no occurrence of c.2045G>A in individuals affected with Lethal Left Ventricular Non-Compaction Delay Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 392943). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at